This compound is primarily utilized in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It has shown potential as a key intermediate in the synthesis of novel therapeutic agents targeting neurological conditions such as anxiety, depression, and cognitive impairments. Its structural properties make it a valuable candidate for modulating specific receptors in the brain, contributing to the development of more effective and targeted treatments. Additionally, it is explored in preclinical studies for its role in enhancing drug delivery systems and improving the bioavailability of CNS-active compounds.